Last10K.com

Cactus Ventures, Inc. (ATNM) SEC Filing 10-K Annual report for the fiscal year ending Monday, December 31, 2012

Actinium Pharmaceuticals, Inc.

HISTORY TOOLS
CIK: 1892322 Ticker: ATNM
Document and Entity Information (USD $)
 12 Months Ended
Dec. 31, 2012
Mar. 26, 2013
Jun. 30, 2012
Document and Entity Information [Abstract]      
Entity Registrant Name Cactus Ventures, Inc.    
Entity Central Index Key 0001388320    
Amendment Flag false    
Current Fiscal Year End Date --12-31    
Document Type 10-K    
Document Period End Date Dec. 31, 2012    
Document Fiscal Year Focus 2012    
Document Fiscal Period Focus FY    
Entity Well-Known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Filer Category Smaller Reporting Company    
Entity Public Float     $ 0
Entity Common Stock, Shares Outstanding   12,053,405  

View differences made from one year to another to evaluate Actinium Pharmaceuticals, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Actinium Pharmaceuticals, Inc..

Continue

Assess how Actinium Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Actinium Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2013 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (parenthetical)
Consolidated Statement Of Changes In Stockholders' Equity
Consolidated Statements Of Operations
Statements Of Cash Flows
Commitments And Contingencies
Commitments And Contingencies (details Textual)
Commitments And Contingencies (details)
Commitments And Contingencies (tables)
Derivatives
Derivatives (details 1)
Derivatives (details Textual)
Derivatives (details)
Derivatives (tables)
Description Of Business And Summary Of Significant Accounting Policies
Description Of Business And Summary Of Significant Accounting Policies (details Textual)
Description Of Business And Summary Of Significant Accounting Policies (details)
Description Of Business And Summary Of Significant Accounting Policies (policies)
Description Of Business And Summary Of Significant Accounting Policies (tables)
Employee Defined Contribution Plan
Employee Defined Contribution Plan (details)
Equity
Equity (details)
Going Concern
Going Concern (details)
Income Taxes
Income Taxes (details 1)
Income Taxes (details Textual)
Income Taxes (details)
Income Taxes (tables)
Note Payable And Convertible Notes
Note Payable And Convertible Notes (details Textual)
Note Payable And Convertible Notes (details)
Note Payable And Convertible Notes (tables)
Property And Equipment
Property And Equipment (details Textual)
Property And Equipment (details)
Property And Equipment (tables)
Related Party Transactions
Related Party Transactions (details Textual)
Related Party Transactions (details)
Related Party Transactions (tables)
Stock Option Plan
Stock Option Plan (details Textual)
Stock Option Plan (details)
Stock Option Plan (tables)
Subsequent Events
Subsequent Events (details)
Warrants
Warrants (details 1)
Warrants (details Textual)
Warrants (details)
Warrants (tables)

Material Contracts, Statements, Certifications & more

Actinium Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 21.1: Subsidiaries
Exhibit 31.1: Certification
Exhibit 32.1: Certification
Ticker: ATNM
CIK: 1388320
Form Type: 10-K Annual Report
Accession Number: 0001213900-13-001417
Submitted to the SEC: Fri Mar 29 2013 1:45:44 PM EST
Accepted by the SEC: Fri Mar 29 2013
Period: Monday, December 31, 2012
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/atnm/0001213900-13-001417.htm